Tech Company Financing Transactions

Cidara Therapeutics Funding Round

Cidara Therapeutics closed a $32 million Series A funding round on 6/30/2014. Backers included 5AM Ventures, Aisling Capital and Frazier Healthcare Partners.

Transaction Overview

Announced On
6/30/2014
Transaction Type
Venture Equity
Amount
$32,000,000
Round
Series A
Investors

5AM Ventures (Lead Investor) (Scott Rocklage)

Aisling Capital (Steven Elms)

Frazier Healthcare Partners (Patrick Heron)

InterWest Partners (Nina Kjellson)

Proceeds Purpose
The funding will enable it to advance candidates from the company's Cloudbreak targeted immunotherapy platform and biafungin, a novel long acting echinocandin antifungal drug, into human clinical studies.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
6310 Nancy Ridge Dr. 101
San Diego, CA 92121
USA
Email Address
Overview
Cidara is focused on developing novel anti-infectives to address serious infections.
Profile
Cidara Therapeutics LinkedIn Company Profile
Social Media
Cidara Therapeutics Company Twitter Account
Company News
Cidara Therapeutics News
Facebook
Cidara Therapeutics on Facebook
YouTube
Cidara Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jeffrey Stein
  Jeffrey Stein LinkedIn Profile  Jeffrey Stein Twitter Account  Jeffrey Stein News  Jeffrey Stein on Facebook
Chief Medical Officer
Taylor Sandison
  Taylor Sandison LinkedIn Profile  Taylor Sandison Twitter Account  Taylor Sandison News  Taylor Sandison on Facebook
Chief Operating Officer
Paul Daruwala
  Paul Daruwala LinkedIn Profile  Paul Daruwala Twitter Account  Paul Daruwala News  Paul Daruwala on Facebook
VP - Bus. Development
Neil Abdollahian
  Neil Abdollahian LinkedIn Profile  Neil Abdollahian Twitter Account  Neil Abdollahian News  Neil Abdollahian on Facebook
VP - Operations
Laura Navalta
  Laura Navalta LinkedIn Profile  Laura Navalta Twitter Account  Laura Navalta News  Laura Navalta on Facebook
VP - R & D
Les Tari
  Les Tari LinkedIn Profile  Les Tari Twitter Account  Les Tari News  Les Tari on Facebook
VP - Regulatory Affairs
Carmen Betancourt
  Carmen Betancourt LinkedIn Profile  Carmen Betancourt Twitter Account  Carmen Betancourt News  Carmen Betancourt on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2014: Yik Yak venture capital transaction
Next: 6/30/2014: Azoti venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary